BABUR BHATTI: Open Payments
NPI 1245525781 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 37 payments from 9 companies in 2025. Trend: 2023 $777 · 2024 $689 · 2025 $1,055
Food & beverage: $980Education: $76
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $278 |
| Teva Pharmaceuticals USA, Inc. | 9 | $252 |
| E.R. Squibb & Sons, L.L.C. | 8 | $207 |
| Vanda Pharmaceuticals Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: COBENFY, INVEGA SUSTENNA, AUSTEDO XR, FANAPT, SPRAVATO, ABILIFY ASIMTUFII, INGREZZA, UZEDY.
Industry payments across FL — which companies pay providers there.
